Devlin Jodi
Chief of Clinical Operations
Devlin Jodi has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Mar 20, 2026.
On the most recent filing, Devlin Jodi is listed as Chief of Clinical Operations at TriSalus Life Sciences, Inc. Inside the rolling window, Devlin Jodi reported no open-market purchases and 3 open-market sales totaling $13K in TLSI. The largest disclosed transaction in the window is a sale of 1,772 TLSI shares on Mar 12, 2026, worth $7K.
Companies traded
Other insiders at TLSI
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$13K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Devlin Jodi made?
Devlin Jodi has filed 2 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Devlin Jodi trade?
Devlin Jodi has filed SEC Form 4 disclosures for 1 company, including TLSI.
When was Devlin Jodi's most recent SEC Form 4 filing?
Devlin Jodi's most recent SEC Form 4 filing on Tracefour is dated Mar 20, 2026.
What is Devlin Jodi's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Devlin Jodi is listed as Chief of Clinical Operations.
What is Devlin Jodi's total buy and sell value in the current window?
Inside the rolling retention window, Devlin Jodi bought $0 and sold $13K based on SEC Form 4 filings.
What was Devlin Jodi's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,772 TLSI shares on 2026-03-12, worth $7K, per SEC Form 4 filings.